Výsledky vyhľadávania - "Lopinavir/adverse effects"

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study

Autori: Yannick Degboé François Montastruc Alexis Revet a ďalší

Prispievatelia: Yannick Degboé François Montastruc Alexis Revet a ďalší

Zdroj: Drug Saf
Drug Safety

Predmety: Male, Hallucinations, Databases, Pharmaceutical, Toxicology, Lopinavir, MESH: Adenosine Monophosphate / analogs & derivatives, 0302 clinical medicine, Monoclonal, 80 and over, Pharmacology (medical), Original Research Article, MESH: Lopinavir / adverse effects, MESH: Aged, Aged, 80 and over, Alanine, Mental Disorders, MESH: Hallucinations / chemically induced, Middle Aged, 3. Good health, Drug Combinations, MESH: Hydroxychloroquine / adverse effects, MESH: COVID-19 Drug Treatment, Female, Hydroxychloroquine, Adult, Humanized / adverse effects, Antibodies, Monoclonal, Humanized, Antiviral Agents, MESH: Databases, MESH: Antiviral Agents / adverse effects, Psychoses, Substance-Induced, 03 medical and health sciences, Humans, MESH: Hallucinations / epidemiology, Aged, MESH: Drug Combinations, Pharmacology, MESH: Adenosine Monophosphate / adverse effects, MESH: Humans, Ritonavir, MESH: Antibodies, MESH: Adult, MESH: Alanine / analogs & derivatives, MESH: Male, Adenosine Monophosphate, Pharmaceutical, MESH: Alanine / adverse effects, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Female, Self-Injurious Behavior

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s40264-020-01013-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33078372

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.

Autori: Young, J. Schäfer, J. Fux, C.A. a ďalší

Prispievatelia: Young, J. Schäfer, J. Fux, C.A. a ďalší

Predmety: Adenine/adverse effects, Adenine/analogs & derivatives, Adult, Benzoxazines/adverse effects, Drug Therapy, Combination/adverse effects, Combination/methods, Female, Glomerular Filtration Rate/drug effects, HIV Infections/drug therapy, HIV Protease Inhibitors/administration & dosage, HIV Protease Inhibitors/adverse effects, Humans, Kidney/drug effects, Kidney/physiopathology, Lopinavir/adverse effects, Male, Middle Aged, Oligopeptides/adverse effects, Organophosphonates/adverse effects, Pyridines/adverse effects, Reverse Transcriptase Inhibitors/administration & dosage, Reverse Transcriptase Inhibitors/adverse effects, Ritonavir/adverse effects, Treatment Outcome

Relation: AIDS; https://iris.unil.ch/handle/iris/242272; serval:BIB_E49D4C7F0E9D; 000301333000006

Dostupnosť: https://iris.unil.ch/handle/iris/242272
https://doi.org/10.1097/QAD.0b013e32834f337c

Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.

Autori: Marzolini, C. Stader, F. Leuppi-Taegtmeyer, A. a ďalší

Predmety: Drug-Related Side Effects and Adverse Reactions, Female, Humans, Long QT Syndrome/chemically induced, Long QT Syndrome/diagnosis, Lopinavir/adverse effects, Male, Pharmaceutical Preparations, SARS-CoV-2, Sex Characteristics, COVID-19 Drug Treatment

Popis súboru: application/pdf

Relation: Drug Safety: The Official Journal of the International Society of Pharmacovigilance; https://iris.unil.ch/handle/iris/118773; serval:BIB_087C444907D1; 000593379200001

Dostupnosť: https://iris.unil.ch/handle/iris/118773
https://doi.org/10.1007/s40264-020-01025-z

Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.

Autori: Stalder, G. Alberio, L.

Zdroj: Blood, vol. 136, no. 7, pp. 915

Predmety: Aged, 80 and over, Antiviral Agents/administration & dosage, Antiviral Agents/adverse effects, Betacoronavirus/drug effects, Betacoronavirus/immunology, Betacoronavirus/pathogenicity, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/pathology, Coronavirus Infections/virology, Drug Combinations, Eryptosis/drug effects, Erythrocytes/drug effects, Erythrocytes/pathology, Erythrocytes/virology, Humans, Lopinavir/administration & dosage, Lopinavir/adverse effects, Lung/diagnostic imaging, Lung/pathology, Lung/virology, Male, Pandemics, Pneumonia, Viral/diagnostic imaging, Viral/drug therapy, Viral/pathology, Viral/virology, Ritonavir/administration & dosage

Popis súboru: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/32790855; info:eu-repo/semantics/altIdentifier/eissn/1528-0020; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4B348B2624955; https://serval.unil.ch/notice/serval:BIB_4B348B262495; https://serval.unil.ch/resource/serval:BIB_4B348B262495.P001/REF.pdf

Dostupnosť: https://serval.unil.ch/notice/serval:BIB_4B348B262495
https://doi.org/10.1182/blood.2020006228
https://serval.unil.ch/resource/serval:BIB_4B348B262495.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_4B348B2624955

Long‐term clinical experience with darunavir (2007–2015) in a large cohort of HIV‐infected patients in Spain

Autori: Pernas, Berta Grandal, Marta Tabernilla, Andrés a ďalší

Prispievatelia: Pernas, Berta Grandal, Marta Tabernilla, Andrés a ďalší

Zdroj: RUC. Repositorio da Universidade da Coruña
instname

Predmety: 0301 basic medicine, Adult, Male, Efficacy, Anti-HIV Agents, HIV Infections/drug therapy, Long Term Adverse Effects, HIV Infections, HIV Protease Inhibitors/administration & dosage, Drug Administration Schedule, Lopinavir, Anti-HIV Agents/administration & dosage, Ritonavir/administration & dosage, 03 medical and health sciences, 0302 clinical medicine, Humans, Lopinavir/adverse effects, RNA, Viral/blood, Darunavir, Retrospective Studies, 0303 health sciences, Sulfonamides, Ritonavir, Sulfonamides/adverse effects, HIV Protease Inhibitors, Viral Load, HIV infection, Viral Load/drug effects, 3. Good health, CD4 Lymphocyte Count, HIV-1/drug effects, Spain, Darunavir/administration & dosage, HIV-1, young adult, RNA, Viral, Drug Therapy, Combination, Female, Safety

Popis súboru: application/pdf

Prístupová URL adresa: https://ruc.udc.es/dspace/bitstream/2183/18373/2/Pernas_Long.pdf
https://pubmed.ncbi.nlm.nih.gov/27218208
http://hdl.handle.net/2183/18373
http://onlinelibrary.wiley.com/doi/10.1002/jmv.24585/abstract
http://europepmc.org/abstract/MED/27218208
https://ruc.udc.es/dspace/handle/2183/18373
https://ruc.udc.es/dspace/bitstream/2183/18373/2/Pernas_Long.pdf
https://hdl.handle.net/2183/18373
https://biblio.vub.ac.be/vubir/longterm-clinical-experience-with-darunavir-20072015-in-a-large-cohort-of-hivinfected-patients-in-spain(b5b097fd-31bf-48e3-a7e6-637a98d2735f).html
https://hdl.handle.net/20.500.14017/b5b097fd-31bf-48e3-a7e6-637a98d2735f
https://doi.org/10.1002/jmv.24585

Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis

Autori: Siemieniuk, Reed A Foroutan, Farid Mirza, Reza a ďalší

Zdroj: ISSN: 2044-6055 ; BMJ Open, vol. 7, no. 9 (2017) e019022.

Predmety: info:eu-repo/classification/ddc/618, Adult, Anti-Retroviral Agents/adverse effects/therapeutic use, Drug Combinations, Emtricitabine/adverse effects/therapeutic use, Female, HIV Infections/complications/drug therapy, Hepatitis B/complications/drug therapy, Humans, Infant, Infectious Disease Transmission, Vertical, Lamivudine/adverse effects/therapeutic use, Lopinavir/adverse effects/therapeutic use, Pregnancy, Pregnancy Complications, Infectious/drug therapy, Pregnancy Outcome, Ritonavir/adverse effects/therapeutic use, Tenofovir/adverse effects/therapeutic use, Young Adult, Zidovudine/adverse effects/therapeutic use

Relation: info:eu-repo/semantics/altIdentifier/pmid/28893758; unige:108128

Dostupnosť: https://archive-ouverte.unige.ch/unige:108128

Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials

Autori: Izcovich, Ariel Siemieniuk, Reed Alexander Bartoszko, Jessica Julia a ďalší

Zdroj: BMJ Open
BMJ Open, Vol 12, Iss 3 (2022)

Predmety: Alanine / adverse effects, Adenosine Monophosphate / adverse effects, Alanine, Ritonavir, SARS-CoV-2, Ritonavir / adverse effects, Lopinavir / adverse effects, Adenosine Monophosphate / analogs & derivatives, Adenosine Monophosphate, Lopinavir, COVID-19 Drug Treatment, 3. Good health, Drug Combinations, Infectious Diseases, Alanine / analogs & derivatives, Medicine, Humans, Hydroxychloroquine / adverse effects, Hydroxychloroquine, Randomized Controlled Trials as Topic

Popis súboru: application/pdf

Prístupová URL adresa: https://www.medrxiv.org/content/medrxiv/early/2020/11/18/2020.11.16.20232876.full.pdf
https://bmjopen.bmj.com/content/bmjopen/12/3/e048502.full.pdf
https://pubmed.ncbi.nlm.nih.gov/35236729
https://doaj.org/article/b54a90ef65534deab17f82632cf7215b
http://medrxiv.org/cgi/content/short/2020.11.16.20232876
https://www.medrxiv.org/content/10.1101/2020.11.16.20232876v1
https://europepmc.org/article/PPR/PPR239364
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/ppmedrxiv-20232876
https://www.medrxiv.org/content/medrxiv/early/2020/11/18/2020.11.16.20232876.full.pdf

Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis

Autori: Olufunmilayo A. Lesi Hassan Mir Yuan Zhang a ďalší

Zdroj: BMJ Open
BMJ Open, Vol. 7, No 9 (2017) P. e019022

Predmety: Adult, Emtricitabine/adverse effects/therapeutic use, Infectious Disease Transmission, Zidovudine/adverse effects/therapeutic use, HIV Infections, Lopinavir, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Hepatitis B/complications/drug therapy, Lopinavir/adverse effects/therapeutic use, Pregnancy, Vertical, Emtricitabine, Humans, Pregnancy Complications, Infectious, Tenofovir, 10. No inequality, Ritonavir/adverse effects/therapeutic use, Lamivudine/adverse effects/therapeutic use, Infectious/drug therapy, ddc:618, Ritonavir, Pregnancy Outcome, Infant, Anti-Retroviral Agents/adverse effects/therapeutic use, Hepatitis B, Infectious Disease Transmission, Vertical, 3. Good health, Pregnancy Complications, Drug Combinations, Anti-Retroviral Agents, Lamivudine, HIV/AIDS, Female, Tenofovir/adverse effects/therapeutic use, Zidovudine, HIV Infections/complications/drug therapy

Popis súboru: application/pdf

Prístupová URL adresa: https://bmjopen.bmj.com/content/bmjopen/7/9/e019022.full.pdf
https://pubmed.ncbi.nlm.nih.gov/28893758
http://bmjopen.bmj.com/content/7/9/e019022
https://archive-ouverte.unige.ch/unige:108128
https://pubmed.ncbi.nlm.nih.gov/28893758/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027063
http://europepmc.org/articles/PMC6027063
https://bmjopen.bmj.com/content/bmjopen/7/9/e019022.full.pdf
https://archive-ouverte.unige.ch/unige:108128

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

Autori: Young, Jim Schäfer, Juliane Fux, Christoph A a ďalší

Zdroj: ISSN: 0269-9370 ; AIDS, vol. 26, no. 5 (2012) p. 567-575.

Predmety: info:eu-repo/classification/ddc/616, Adenine/adverse effects/analogs & derivatives, Adult, Benzoxazines/adverse effects, Drug Therapy, Combination/adverse effects/methods, Female, Glomerular Filtration Rate/drug effects, HIV Infections/drug therapy, HIV Protease Inhibitors/administration & dosage/adverse effects, Humans, Kidney/drug effects/physiopathology, Lopinavir/adverse effects, Male, Middle Aged, Oligopeptides/adverse effects, Organophosphonates/adverse effects, Pyridines/adverse effects, Reverse Transcriptase Inhibitors/administration & dosage/adverse effects, Ritonavir/adverse effects, Treatment Outcome

Relation: info:eu-repo/semantics/altIdentifier/pmid/22398568; unige:31635

Dostupnosť: https://archive-ouverte.unige.ch/unige:31635